Uncy stock price.

According to the issued ratings of 4 analysts in the last year, the consensus rating for Unicycive Therapeutics stock is Buy based on the current 4 buy ratings for UNCY. The average twelve-month price prediction for Unicycive Therapeutics is $10.83 with a high price target of $24.00 and a low price target of $4.00.UNCY Stock Price Chart Interactive Chart > Unicycive Therapeutics, Inc., (UNCY) Company Bio Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States.BBIO | Complete BridgeBio Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Unicycive Therapeutics Third Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.37 loss in 3Q 2022) Unicycive Therapeutics ( NASDAQ:UNCY ) Third Quarter 2023 Results Key Financial Results Net ...

UNCY - Unicycive Therapeutics Inc Ordinary Shares Stock Price Quote - NASDAQ | Morningstar Unicycive Therapeutics Inc Ordinary Shares UNCY Morningstar Rating | Rating as of Oct 10, 2023...View UNCY revenue estimates and earnings estimates, ... Stock Price Target. High: $4.50: Low: $4.50: Average: $4.50: Current Price: $0.6113: UNCY will report FY 2023 earnings on 03/31/2023.View live Unicycive Therapeutics, Inc. chart to track its stock's price action. Find market predictions, UNCY financials and market news.

Discover historical prices for GM stock on Yahoo Finance. View daily, weekly or monthly format back to when General Motors Company stock was issued.

Find the latest Novo Integrated Sciences, Inc. (NVOS) stock quote, history, news and other vital information to help you with your stock trading and investing.Features and Tutorials. Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. We keep you up to …Holders of ENPH stock are celebrating this news today with a 3.3% boost to the share price. That comes alongside some 1.6 million shares changing hands. ... (NASDAQ: UNCY) stock are moving today.Entera Bio Ltd. 0.7123. UNCH. UNCH. Get Unicycive Therapeutics Inc (UNCY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Find the latest GE HealthCare Technologies Inc. (GEHC) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest Tilray Brands, Inc. (TLRY) stock quote, history, news and other vital information to help you with your stock trading and investing.

The Unicycive Therapeutics, Inc. stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of UNCY stock is predicted to rise by 2.33% tomorrow and lose -32.55% in the next 7 days.

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are ...About the Unicycive Therapeutics Inc stock forecast. As of 2023 December 01, Friday current price of UNCY stock is 0.50010$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Unicycive Therapeutics stock price has been showing a declining tendency so we believe that similar market …Share Price. as of November 27 1:44:54 PM EST. About Incyte. Incyte Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of proprietary small ... Find the latest UnitedHealth Group Incorporated (UNH) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest WW International, Inc. (WW) stock quote, history, news and other vital information to help you with your stock trading and investing.Get historical data for the S&P 500 (^GSPC) on Yahoo Finance. View and download daily, weekly or monthly data to help your investment decisions.

Incyte Corporation stock performance at a glance. Check Incyte Corporation’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. View the latest Huntington Bancshares Inc. (HBAN) stock price, news, historical charts, analyst ratings and financial information from WSJ.LOS ALTOS, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, ... Stock Price data may be delayed up to 15 minutes.On May 17, 2023, Unicycive Therapeutics Inc (UNCY) saw a significant increase in its stock price following the release of optimistic price forecasts from 5 analysts. The median target price for the company over the next 12 months is $5.00, which represents a staggering 259.71% increase from the last price of $1.39.The current price of the stock makes it a good time to buy, despite a recent ramp in the stock price. The 52-week low was $62.31, but the stock closed at $76.95 on November 1, reasonably close to ...

The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates.Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.

Overview News Ideas Financials Technicals Forecast UNCY chart Today 4.29% 5 days 12.56% 1 month −17.92% 6 months −57.70% Year to date 16.57% 1 year −15.53% 5 years −92.93% All time −92.93% Key stats Market capitalization 21.023M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −1.7331 USD Net income −18.058M USD RevenueUnicycive Therapeutics, Inc. (UNCY) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.4900 -0.0225 (-4.39%) At close: 03:59PM EST 0.5145 +0.02 …UNCY is lower by -$0.02 from the previous closing price of $1.52 on volume of 425,135 shares. Over the past year the S&P 500 has gained 3.20% while UNCY has risen 111.27%. UNCY lost -$1.20 per share the over the last 12 months. Click Here to get the full Stock Report for Unicycive Therapeutics Inc stock. The 55 rating InvestorsObserver gives to ...UNCY: Unicycive Therapeutics Inc Stock Price Quote - NASDAQ CM - Bloomberg Subscribe S&P 500 4,559.34 +0.06% Nasdaq 14,250.85 –0.11% Crude Oil 75.18 –2.49% …It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Mar 8, 2023 · H.C. Wainwright analyst Ed Arce maintained a Buy rating on Unicycive Therapeutics (UNCY – Research Report) today and set a price target of $8.00.The company’s shares opened today at $1.44 ... View the latest Incyte Corp. (INCY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Earnings for Indaptus Therapeutics are expected to grow in the coming year, from ($1.90) to ($1.73) per share. Indaptus Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 15th, 2024 based off prior year's report dates. Read More.View the latest Amazon.com Inc. (AMZN) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Stock analysis for Incyte Corp (INCY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Unicycive Therapeutics (UNCY) has the following price history information. Looking back at UNCY historical stock prices for the last five trading days, on March 24, 2023, UNCY opened at $1.85, traded as high as $1.98 and as low as $1.80, and closed at $1.91. Trading volume was a total of 432.60K shares. On March 27, 2023, UNCY opened at $1.88, …

The Incyte Corporation stock price gained 0.637% on the last trading day (Friday, 24th Nov 2023), rising from $53.40 to $53.74. During the last trading day the stock fluctuated 1.08% from a day low at $53.21 to a day high of $53.78. The price has risen in 7 of the last 10 days and is up by 2.32% over the past 2 weeks.Find the latest HUB Cyber Security Ltd. (HUBC) stock quote, history, news and other vital information to help you with your stock trading and investing.Raymond kept his overweight rating and 100 price target on Incyte stock. Incyte's Outlook For 2023. For the year, Incyte guided to $2.55 billion to $2.63 billion in Jakafi sales and to $215 ...View the latest T-Mobile US Inc. (TMUS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Source: Kantar Media. View the latest Unicycive Therapeutics Inc. (UNCY) stock price, news, historical charts, analyst ratings and financial information from WSJ.Range Low Price High Price Comment; 30 days: $51.47: $55.50: Friday, 1st Dec 2023 INCY stock ended at $54.02.This is 0.589% less than the trading day before Thursday, 30th Nov 2023. . During the day the stock fluctuated 1.85% from a day low at $53.62 to a day high of $54.1 ene 2023 ... ... Price-Earnings Ratios and Implied Real Earnings Growth in Major Stock ... uncy, over. 80 percent of market participanL' accept l1.S. government se ...Discover historical prices for GME stock on Yahoo Finance. View daily, weekly or monthly format back to when GameStop Corp. stock was issued.

View the latest Johnson & Johnson (JNJ) stock price, news, historical charts, analyst ratings and financial information from WSJ.Find the latest Tilray Brands, Inc. (TLRY) stock quote, history, news and other vital information to help you with your stock trading and investing.Discover historical prices for DIS stock on Yahoo Finance. View daily, weekly or monthly format back to when The Walt Disney Company stock was issued.2 Wall Street analysts have issued twelve-month price targets for First Wave BioPharma's stock. Their FWBI share price targets range from $10.00 to $10.00. On average, they anticipate the company's share price to reach $10.00 in the next twelve months. This suggests a possible upside of 3,497.1% from the stock's current price.Instagram:https://instagram. usig etfworth of a 1921 silver dollarcardaxstarpax stock Find the latest Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock quote, history, news and other vital information to help you with your stock trading and investing. vinfast stock vfs stock pricemarket movers today stock 4 brokerages have issued 12-month target prices for Unicycive Therapeutics' shares. Their UNCY share price targets range from $4.00 to $24.00. On average, they predict the company's share price to reach $10.83 in the next twelve months. This suggests a possible upside of 2,110.9% from the stock's current price. cyber etf Dec 4, 2023 · On December 4, 2023, Incyte (NASDAQ:INCY) received a significant boost as Guggenheim analyst Michael Schmidt upgraded the company’s rating from Neutral to Buy. Schmidt set a price target of $86.00 for the stock, indicating a positive outlook on Incyte’s performance. This upgrade aligns with the consensus among analysts, who have an average ... Stock Chart (Intraday). 3.21.12 Price Nasdaq: UNCY. 3.21.12 ... Penny stocks are low-priced shares typically issued by small companies. Penny stocks involve ...Nov 2, 2022 · The current price of the stock makes it a good time to buy, despite a recent ramp in the stock price. The 52-week low was $62.31, but the stock closed at $76.95 on November 1, reasonably close to ...